Symmetry Partners’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Symmetry Partners's DGX Position: Q3 2024 in Review
Symmetry Partners sold out of Quest Diagnostics (DGX) in Q3 2024, closing a stake of 4,668 shares — an estimated $639K sold.
Symmetry Partners first reported a position in DGX in Q4 2018 and held it in 20 quarters. The position peaked at $1.06M in Q3 2020. 847 funds tracked by Wall St. Rank hold DGX as of Q3 2024.
- Symmetry Partners reported no remaining Quest Diagnostics position as of Q3 2024 after selling out during the quarter.
- Symmetry Partners sold 4,668 Quest Diagnostics shares in Q3 2024, an estimated $639K.
- Symmetry Partners first reported a position in Quest Diagnostics in Q4 2018 and held it in 20 quarters.
- Symmetry Partners's Quest Diagnostics position peaked at $1.06M in Q3 2020.
- 847 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2024.
Based on Symmetry Partners's 13F filing for Q3 2024, filed 29 Oct 2024.